期刊
JOURNAL OF MOLECULAR BIOLOGY
卷 411, 期 2, 页码 329-333出版社
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jmb.2011.05.046
关键词
Parkinson's disease; alpha-synuclein; aggregation; posttranslational modification; linear growth theory
资金
- National Institutes of Health [GM065790]
- Elan Pharmaceuticals
- St. John's College, Cambridge
- Schiff Foundation
- Wellcome Trust
- Leverhulme Trust
- Medical Research Council [MC_G1000734] Funding Source: researchfish
- MRC [MC_G1000734] Funding Source: UKRI
alpha-Synuclein (alpha-syn) is the major component of filamentous Lewy bodies found in the brains of patients diagnosed with Parkinson's disease (PD). Recent studies demonstrate that, in addition to the wild-type sequence, alpha-syn is found in several modified forms, including truncated and phosphorylated species. Although the mechanism by which the neuronal loss in PD occurs is unknown, aggregation and fibril formation of alpha-syn are considered to be key pathological features. In this study, we analyze the rates of fibril formation and the monomer fibril equilibrium for eight disease-associated truncated and phosphorylated alpha-syn variants. Comparison of the relative rates of aggregation reveals a strong monotonic relationship between the C-terminal charge of alpha-syn and the lag time prior to the observation of fibril formation, with truncated species exhibiting the fastest aggregation rates. Moreover, we find that a decrease in C-terminal charge shifts the equilibrium to favor the fibrillar species. An analysis of these findings in the context of linear growth theories suggests that the loss of the charge-mediated stabilization of the soluble state is responsible for the enhanced aggregation rate and increased extent of fibril fraction. Therefore, C-terminal charge is kinetically and thermodynamically protective against alpha-syn polymerization and may provide a target for the treatment of PD. (C) 2011 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据